Is There a Trade-Off Between Immunability and Inflexibility?

Most of these protocols, these projects are less than two years old. So that's obviously a positive and that kind of solves some of the principal agent problem in corporate finance. I think this kind of gets up the idea of credible neutrality. And so on the far end of that spectrum, you have governance minimization. But if you're really looking to build something where the core value prop is other people built on top of what you're building, then I think erring on the side of actually resiliency and robustness with the option to upgrade slowly over time makes a lot of sense.

Transcript

Play full episode

Transcript

Episode notes

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app